Not investment advice. Educational platform. See Disclaimer.
NASDAQ: TEM
Tempus AI, Inc.
Healthcare | Medical - Healthcare Information Services
No licensed closing price on file for TEM. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.
EPS (FY2025)$-1.41
Tempus AI, Inc. (NASDAQ: TEM) is a health information company. Figures from SEC EDGAR; updated 2026-10-20 09:47 UTC.
What Tempus AI, Inc. does
Tempus AI is a healthcare technology company that applies artificial intelligence to laboratory testing to make diagnoses more accurate and personalized by connecting test results to patients' clinical data. The company built the Tempus Platform, a technology system and operating system that aggregates clinical and molecular oncology data from healthcare institutions through hundreds of data connections across thousands of sites.
Summarized from Tempus AI, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗
Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.
Tempus AI is a healthcare technology company that applies artificial intelligence to laboratory testing to make diagnoses more accurate and personalized by connecting test results to patients' clinical data.
When did TEM last file with the SEC?
Tempus AI, Inc.'s most recent SEC filing on record is a 8-K filed 2026-05-22. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 09:47 UTC. This page is also available as JSON at /api/data?ticker=TEM and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for TEM and 5,000+ tickers.